Key result
ClinGen Expert Panel establishes consensus guidelines to standardize classification of ~2,300 LDLR variants in FH.
Answers are grounded in this paper and cite their sources.
Purpose In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published consensus standardized guidelines for variant classification in Mendelian disorders. To increase accuracy and consistency, the Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia (FH) Variant Curation Expert Panel (VCEP) was tasked with optimizing the existing ACMG/AMP framework for disease-specific classification in FH. Here, we provide consensus recommendations for the most common FH-causing gene, LDLR , where >2,300 unique FH-associated variants have been identified. Methods The multidisciplinary FH VCEP met in person and through frequent emails and conference calls to develop LDLR -specific modifications of ACMG/AMP guidelines. Through iteration, pilot testing, debate and commentary, consensus among experts was reached. Results The consensus LDLR variant modifications to existing ACMG/AMP guidelines include: 1) alteration of population frequency thresholds; 2) delineation of loss-of-function variant types; 3) functional study criteria specifications; 4) co-segregation criteria specifications; and 5) specific use and thresholds for in silico prediction tools, among others. Conclusion Establishment of these guidelines as the new standard in the clinical laboratory setting will result in a more evidence-based, harmonized method for LDLR variant classification worldwide, thereby improving the care of FH patients.
No takes yet. Share an insight, caveat, or question.
Chora et al. (2021) studied Familial Hypercholesterolemia. ClinGen FH VCEP consensus LDLR variant classification guidelines vs. 2015 ACMG/AMP variant classification framework was evaluated on LDLR-specific modifications of ACMG/AMP variant classification guidelines. The ClinGen FH Variant Curation Expert Panel established consensus ACMG/AMP guideline modifications for classifying >2,300 unique LDLR variants in familial hypercholesterolemia.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: